for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Bio-Thera Solutions Ltd

688177.SS

Latest Trade

48.32CNY

Change

0.69(+1.45%)

Volume

865,860

Today's Range

47.11

 - 

48.46

52 Week Range

41.25

 - 

78.00

As of on the Shanghai Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
47.63
Open
48.11
Volume
865,860
3M AVG Volume
41.71
Today's High
48.46
Today's Low
47.11
52 Week High
78.00
52 Week Low
41.25
Shares Out (MIL)
414.08
Market Cap (MIL)
20,008.35
Forward P/E
-30.97
Dividend (Yield %)
--

Latest Developments

More

Bio-Thera Solutions' H1 Net Loss Narrows To 243.8 M;n Yuan

Bio-Thera Solutions Plans To Issue H-Shares And List In Hong Kong

Bio-Thera Solutions' Net Losses Widen In 2019, Q1

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Bio-Thera Solutions Ltd

Bio-Thera Solutions, Ltd. is a China-based company mainly engaged in the research and development of innovative drugs and biosimilars. The Company is committed to the development of a new generation of antibody drugs to treat cancer, autoimmune diseases, cardiovascular diseases and other major diseases that endanger human life and health. The Company's main products include adalimumab BAT1406, bevacizumab BAT1706, BAT8001, tocilizumab BAT1806, batifaban BAT2094, BAT8003 and so on.

Industry

Biotechnology & Drugs

Contact Info

+86.20.32203220

https://www.bio-thera.com/

Key Stats

2.00 mean rating - 1 analysts
Sell
Hold
Buy
Revenue (MM, CNY)

2019

0.0K
EPS (CNY)

2019

-2.960
Price To Earnings (TTM)
--
Price To Sales (TTM)
404.32
Price To Book (MRQ)
8.79
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
4.41
LT Debt To Equity (MRQ)
0.00
Return on Investment (TTM)
-34.24
Return on Equity (TTM)
-29.31

Latest News

Latest News

BRIEF-Bio-Thera Solutions' H1 Net Loss Narrows To 243.8 M;n Yuan

* SAYS H1 NET LOSS NARROWS TO 243.8 MILLION YUAN ($35.41 million) FROM 715.1 MILLION YUAN YEAR EARLIER Source text in Chinese: https://bit.ly/34Ep88u Further company coverage: ($1 = 6.8841 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)

BRIEF-Bio-Thera Solutions Plans To Issue H-Shares And List In Hong Kong

* SAYS IT PLANS TO ISSUE H-SHARES AND LIST IN HONG KONG STOCK EXCHANGE Source text in Chinese: https://bit.ly/3d6AJhl Further company coverage: (Reporting by Hong Kong newsroom)

BRIEF-Bio-Thera Solutions' Net Losses Widen In 2019, Q1

* SAYS 2019 NET LOSS WIDENS TO 1.0 BILLION YUAN ($141.33 million) FROM 553.1 MILLION YUAN YEAR EARLIER

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up